Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

Journal of Clinical Investigation

Volumn 97, Issue 7, 1996, Pages 1715-1722

  Brand, Korbinian ^a,d   Page, Sharon ^a   Rogler, Gerhard ^b   Bartsch, Armin ^a   Brandl, Richard ^a   Knuechel, Ruth ^b   Page, Michael ^a   Kaltschmidt, Christian ^c   Baeuerle, Patrick A ^c,e   Neumeier, Dieter ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e AMGEN INC   (United States)

Author keywords

endothelial cells; I B; macrophages; p65; smooth muscle cells

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION;

EID: 13344261982     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118598     Document Type: Article

References (51)

1. Lenardo, M.J., and D Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
2. Baeuerle, P.A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys Acta 1072:63-80.
3. Grilli, M., J.J.-S. Chiu, and M.J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol 143:1-62.
4. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol 12:141-179.
5. Baeuerle, P.A., and D. Baltimore 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Wash. DC) 242:540-546.
6. Cheng, Q., C.A. Cant, T. Moll, R. Hofer-Warbinek, E. Wagner, M.L. Birnstiel, F.H. Bach, and R. de Martin. 1994. NF-kappa B subunit-specific regulation of the I kappa B-alpha promoter J Biol. Chem 296.13551-13557.
7. Muller, J M , H.W.L. Ziegler-Heitbrock, and P A. Baeuerle. 1993 Nuclear factor kappa B, a mediator of lipopolysaccharide effects Immunobiology. 187. 233-256.
8. Witztum, J.L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
9. Berliner, J.A., M. Territo, A. Andalibi, M. Navab, F. Liao, S Gushing, S. Imes, J Kim, B. van Lenten, A J. Lusis, and A M. Fogelman. 1992 Modified lipoproteins and atherogenesis. In Cellular and Molecular Biology of Atherosclerosis J.A.M. Gotto, editor. Springer-Verlag London Ltd., London. 77-80.
10. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
11. Collins. T. 1993. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68:499-508.
12. Qwarnström, E.E., C.O. Ostberg, G.L. Turk, C.A. Richardson, and K. Bomsztyk. 1994. Fibronectin attachment activates the NF-κB p50/p65 heterodimer in fibroblasts and smooth muscle cells. J. Biol. Chem. 269:30765-30768.
13. Gown, A.M., T. Tsukada, and R. Ross. 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions Am. J. Pathol. 125:191-207.
14. Barath, P., M.C. Fishbein, J. Lao, J Bernson, R.H Helfaut, and J.S. Forrester 1990. Tumor necrosis factor gene expression in human vascular smooth muscle cells detected by in vitro hybridization. Am. J Pathol. 137.503-509.
15. Beutler, B., and C. van Huffel 1994. An evolutionary and functional approach to the TNF receptor/ligand family. Ann NY Acad. Sci. 730:118-133.
16. Hiscott, J., J. Marois, J. Garoufalis, M. D'Addarion, A Roulston, I. Kwan, N. Pepin, J. Lacoste, H. Nguyen, G Bensi, and M. Fenton. 1993. Characterization of a functional NF-kappa B site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol Cell. Biol 13:6231-6240.
17. Rosenfeld, M.E., S Yla-Herttuala, B.A. Lipton, V.A. Ord, J.L. Witztum, and D. Steinberg. 1992. Macrophage colony-stimmulatuig factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am. J. Pathol. 140: 291-300.
18. Clinton, S.K., R. Underwood, L. Haynes, M.L. Sherman, D.W. Kufe, and P. Libby. 1992. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-316.
19. Ylä-Herttuala, S., B.A. Lipton, M.E. Rosenfeid, T. Särkioja, T. Yoshimura, E.J. Leonard, J L Witztum, and D. Steinbeig. 1991. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci USA 88 5252-5256.
20. Wilcox, J.N., K.M. Smith, S.M. Schwartz, and D. Gordon. 1989. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl Acad. Sci. USA. 86:2839-2843.
21. Brand, K., B.J. Fowler, T.S. Edgington, and N. Mackman. 1991. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol. Cell. Biol. 11: 4732-4738.
22. Mackman, N., K. Brand, and T.S. Edgington. 1991 Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J Exp Med. 174.1517-1526.
23. Edgington, T.S., N Mackman, K. Brand, and W. Ruf. 1994. The structural biology of expression and function of tissue factor. Thromb. Haemost. 66: 67-79.
24. Cybulsky, M.I., and M.A. Gimbrone, Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash DC). 251:788-791.
25. Neish, A.S , A J. Williams, H.J. Palmer, M.Z. Whitley, and T. Collins. 1992. Functional analysis of the human vascular cell adhesion molecule-1 promotor. J Exp. Med. 176:1583-1593.
26. Iademarco, M.F., J J. McQuillan, G.D. Rosen, and D.C. Dean. 1992 Characterization of the promotor for vascular cell adhesion molecule-1 (VCAM-1). J. Biol Chem. 267:16323-16329.
27. Poston, R N., D.O. Haskard, J R Coucher, N.P Gall, and R.R. Johnson-Tidey. 1992. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques Am. J. Pathol 140:665-673.
28. Duyao, M.P., A.J Buckler, and G.E Sonenshein. 1990 Interaction of an NF-κB like factor with a site upstream of the c-myc promotor. Proc. Natl. Acad. Sci. USA. 87:4727-4731.
29. Parhami, F., Z.T. Fang, A.M. Fogelman, A Andalibi, M.C. Territo, and J.A Berliner. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:471-478.
30. Liao, F., A. Andalibi, J.-H. Qiao, H Allayee, A.M. Fogelman, and A.J. Lusis 1994. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin Invest. 94:877-884.
31. Rajavashisth, T.B., A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, A.M. Fogelman, and A.J. Lusis. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature (Lond.) 344.254-257.
32. Hamilton, T.A , G. Ma, and G.M. Chisholm 1990. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:2343-2350.
33. Fong, L.G., T.A.T. Fong, and A.D. Cooper. 1991. Inhibition of lipopolysaccharide-induced interleukin-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein J Lipid Res. 32.1899-1910.
34. Brand, K., C L. Banca, N Mackman, R.A. Terkeltaub, S T. Fan and L.K. Curtiss 1994. Oxidized low density lipoprotein enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler. Thromb. 14:790-797.
35. Terkeltaub, R., C.L Banca, J. Solan, D. Santoro, K Brand, and L K Curtiss. 1994. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14:47-53.
36. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P A. Baeuerle. 1994. Constitutive NF-κB activity in neurons Mol. Cell. Biol 14: 3981-3992.
37. Kaltschmidt, C., B. Kaltschmidt, J. Lannes-Vieira, G. W. Kreutzberg, H. Wekerle, P.A. Baeuerle, and J. Gehrmann. 1994 Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55:99-106.
38. Kaltschmidt, C., B. Kaltschmidt, T. Henkel, H. Stockinger, and P.A. Baeuerle 1995. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe-Seyler. 376:9-16.
39. Levey, A.I., J.P. Bolam, D.B. Rye, A.E. Hallanger, R.M. Demuth, M -M. Mesulam, and B.H. Wainer. 1986. A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. J. Histochem. Cytochem. 34:1449-1457.
40. Masuda, J., and R. Ross. 1990. Atherogenesis during low level hypercholesterolemia in the non human primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis. 10:178-187.
41. Badimon, J J., V. Fuster, J.H. Chesebro, and L. Badimon. 1993. Coronary atherosclerosis: a multifactorial disease. Circulation 87:II3-II16.
42. Leenen, P J., M.F. Bruijn, J.S. Voerman, P.A. Campbell, and W. Ewijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods. 174:5-19.
43. Amento, E.P., N Ehsani, H Palmer, and P. Libby 1991. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 11.1223-1230.
44. Nakajima, T., I. Kitajima, H. Shin, I. Takasaki, K. Shigeta, K. Abeyama, Y. Yamashita, T. Tokioka, Y. Soejima, and I. Maruyama. 1994. Involvement of NF-κB activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem Biophys. Res. Commun. 204:950-955.
45. Libby, P., and G.K. Hansson. 1991. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:5-15.
46. Brand, K., N Mackman, and L.K. Curtiss. 1993. Interferon-γ inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J. Clin. Invest. 91:2031-2039.
47. Wu, H., K. Moulton, A. Horvai, S. Parik, and C.K. Glass. 1994. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol. 14:2129-2139.
48. Marui, N., M.K. Offermann, R. Swerlick, C. Kunsch, C.A. Rosen, M. Ahmad, R.W. Alexander, and R.M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866-1874.
49. Weber, C., W. Erl, A. Pietsch, M. Strobel, H.W.L. Ziegler-Heitbrock, and P C Weber. 1994. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 14 1665-1673.
50. Ferrell, M., V. Fuster, H.K. Gold, and J H Chesebro 1992. A dilemma for the 1990s choosing appropriate experimental animal model for the prevention of restenosis. Circulation. 85 1630-1631.
51. Dartsch, P.C., G. Bauriedel, I. Schinko, H.-D. Weiss, B. Höfling, and E. Betz. 1989. Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneus atherectomy. Atherosclerosis. 80: 149-157.